RGEN Q1 2019 Earnings — Repligen Corporation Revenue & Financial Results | Market Cap Arena

RGENRepligen Corporation

$7B

Q1 2019 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$61M+35.3% YoY

Gross Profit

$34M55.7% margin

Operating Income

$11M18.4% margin

Net Income

$8M13.3% margin

EPS (Diluted)

$0.17

QoQ Revenue Growth

+16.7%

Cash Flow

Operating Cash Flow

$10M

Free Cash Flow

$6M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$798M

Total Liabilities

$173M

Stockholders' Equity

$625M

Cash & Equivalents

$196M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$61M	$45M	+35.3%
Gross Profit	$34M	$25M	+34.3%
Operating Income	$11M	$6M	+86.9%
Net Income	$8M	$3M	+133.6%

Revenue Segments

Filtration Products

$29M48%

Protein Products

$17M27%

Chromatography Products

$14M23%

Other products

$1M2%